Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-30

Clinical Trial Update: A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection [EARLY_Phase 1]

View source ↗

Summary

A Phase 0/I study evaluating ribociclib in combination with everolimus in preoperative recurrent high-grade glioma patients scheduled for resection. Results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Everolimus (everolimus)
  • Ribociclib (ribociclib)

Snippet

Sponsor: St. Joseph's Hospital and Medical Center, Phoenix | Conditions: Glioblastoma Multiforme, Glioma of Brain | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-05-30